Topics

Approximately 70 medical students, residents and faculty members from the Jacobs School of Medicine and Biomedical Sciences sat down to a Sept. 6 dinner with dozens of community members.

Researchers in the Department of Pathology and Anatomical Sciences have made surprising findings that challenge long-held scientific beliefs while studying the chewing behavior of carnivorans, the large mammalian order that includes dogs, cats and bears.

Jacobs School of Medicine and Biomedical Sciences medical students in the Class of 2022 have passed a milestone signifying the beginning of their medical careers: the traditional white coat ceremony.

New information from Department of Biochemistry researchers on how manganese gets into the brain is helping to shed light on a neurological disorder usually associated with industrial overexposure to the metal.

UB’s Clinical and Translational Science Institute (CTSI) has announced $3 million in funding for the development and testing of methods to bring evidence-based findings into routine clinical practice.

A preclinical study conducted by researchers in the Department of Pharmacology and Toxicology has shown for the first time that a class of proteins are important in the neurobiology of relapse or drug-seeking behaviors.

David Dietz, PhD, associate professor, has been appointed chair of the Department of Pharmacology and Toxicology.

Seventy-five student-scientists presented projects during the Eighth Annual Buffalo Summer Research Conference, an interdisciplinary forum marking the culmination of their summer research in Buffalo.

New research led by Panayotis (Peter) K. Thanos, PhD, a senior research scientist specializing in behavioral neuropharmacology at UB’s Research Institute on Addictions and the Department of Pharmacology and Toxicology, shows that exercise can help prevent relapse into cocaine addiction.

John R. Fudyma, MD, clinical associate professor of medicine and chief of general internal medicine, was honored with the Laureate Award from the New York Chapter of the American College of Physicians (ACP).

Research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified a new drug target for remyelination in multiple sclerosis (MS).

Imagine a pathogen that infects completely healthy people and can cause blindness in one day and flesh-eating infections, brain abscesses and death in just a few days. Now imagine that this pathogen is also resistant to all antibiotics.

Twelve projects and their researchers were recognized as best in their respective categories during the Department of Medicine’s sixth annual Research Day.

One hundred eighty-nine new doctors donned their long white coats for the first time during a ceremony at the new home of the Jacobs School of Medicine and Biomedical Sciences in downtown Buffalo.

Researchers in the Department of Medicine’s Division of Geriatrics and Palliative Medicine have found that low levels of vitamin D may impair stamina and performance over time.

Twelve faculty members with varied research and clinical expertise — representing four medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.

Researchers at the Hunter James Kelly Research Institute (HJKRI) have been awarded a pair of grants for the investigation of mechanisms underlying axonal degeneration in certain neurological disorders.

Research led by Paresh Dandona, MD, PhD, has shown that adding liraglutide to insulin treatment for patients with Type 1 diabetes provides health benefits.

Newly published research led by Robert Zivadinov, MD, PhD, professor of neurology, finds novel indicators for predicting worsening conditions in multiple sclerosis (MS) patients.